Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Current Opinion in Oncology|March 15, 2021
Emerging systemic antitarget treatment for differentiated thyroid carcinomaNeus Basté, Mireia Mora, Juan José GrauEndocrinologia, Diabetes Y Nutricion|November 16, 2020
Familial non medullary thyroid carcinoma: Beyond the syndromic formsAida Orois, Mireia Mora, Irene Halperin, et al.Endocrinologia, Diabetes Y Nutricion|July 16, 2021
Familial non medullary thyroid carcinoma: Beyond the syndromic formsAida Orois, Mireia Mora, Irene Halperin, et al.Waste Management (New York, N.Y.)|June 18, 2023
Dialysis and column chromatography for biomass pyrolysis liquids separationMireia Mora, Esteve Fàbregas, Francisco Céspedes, et al.Clinical Endocrinology|April 23, 2014
Metabolic and hormonal contributors to survival in the participants of the Mataró Ageing Study at 8 years follow-upMireia Mora, Mateu Serra-Prat, Elisabet Palomera, et al.Age (Dordrecht, Netherlands)|April 23, 2013
Obestatin is associated to muscle strength, functional capacity and cognitive status in old womenMireia Mora, María Luisa Granada, Elisabet Palomera, et al.Endocrinologia, Diabetes Y Nutricion|February 2, 2019
Effects of sex steroids on cardiovascular risk profile in transgender men under gender affirming hormone therapyGloria Aranda, Mireia Mora, Felicia A Hanzu, et al.Radiology Case Reports|December 10, 2024
Partial biochemical response of adrenal artery embolization for pheochromocytoma: A case report and review of the literatureFernando Choque-Chávez, Alfredo Páez-Carpio, Mireia Mora, et al.Surgical Endoscopy|April 25, 2013
Weight loss is a major contributor to improved sexual function after bariatric surgeryMireia Mora, Gloria Beatriz Aranda, Ana de Hollanda, et al.Frontiers in Endocrinology|October 18, 2021
Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender PopulationGloria Aranda, Irene Halperin, Esther Gomez-Gil, et al.Pageof 9